Penn Davis Mcfarland Inc. Buys Shares of 30,149 U.S. Physical Therapy, Inc. (NYSE:USPH)

Penn Davis Mcfarland Inc. acquired a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 30,149 shares of the company's stock, valued at approximately $2,552,000. Penn Davis Mcfarland Inc. owned approximately 0.20% of U.S. Physical Therapy as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy in the second quarter valued at approximately $28,000. Innealta Capital LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $30,000. Quest Partners LLC raised its holdings in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company's stock valued at $32,000 after acquiring an additional 337 shares in the last quarter. Quarry LP grew its holdings in U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock worth $48,000 after acquiring an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth about $51,000.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded down $1.31 during mid-day trading on Monday, reaching $83.44. The stock had a trading volume of 103,848 shares, compared to its average volume of 89,509. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The business has a 50 day simple moving average of $83.45 and a 200 day simple moving average of $93.24. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 78.93, a PEG ratio of 4.02 and a beta of 1.39. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.76 earnings per share. On average, analysts expect that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy's dividend payout ratio is currently 166.04%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin acquired 2,000 shares of the company's stock in a transaction dated Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the purchase, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. In other news, COO Graham D. Reeve sold 1,724 shares of the business's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The shares were bought at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the purchase, the director now owns 18,904 shares of the company's stock, valued at $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

USPH has been the subject of a number of research reports. Bank of America reaffirmed a "neutral" rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reaffirmed an "outperform" rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th. Finally, StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.